How can we create precision immunotherapy as standard in breast cancer?
Publication
, Journal Article
Hartman, ZC
Published in: Expert Rev Anticancer Ther
November 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Expert Rev Anticancer Ther
DOI
EISSN
1744-8328
Publication Date
November 2021
Volume
21
Issue
11
Start / End Page
1179 / 1181
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasms
- Immunotherapy
- Immunologic Factors
- Humans
- Female
- Cancer Vaccines
- Breast Neoplasms
- Antigens, Neoplasm
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Hartman, Z. C. (2021). How can we create precision immunotherapy as standard in breast cancer? Expert Rev Anticancer Ther, 21(11), 1179–1181. https://doi.org/10.1080/14737140.2021.1951241
Hartman, Zachary C. “How can we create precision immunotherapy as standard in breast cancer?” Expert Rev Anticancer Ther 21, no. 11 (November 2021): 1179–81. https://doi.org/10.1080/14737140.2021.1951241.
Hartman ZC. How can we create precision immunotherapy as standard in breast cancer? Expert Rev Anticancer Ther. 2021 Nov;21(11):1179–81.
Hartman, Zachary C. “How can we create precision immunotherapy as standard in breast cancer?” Expert Rev Anticancer Ther, vol. 21, no. 11, Nov. 2021, pp. 1179–81. Pubmed, doi:10.1080/14737140.2021.1951241.
Hartman ZC. How can we create precision immunotherapy as standard in breast cancer? Expert Rev Anticancer Ther. 2021 Nov;21(11):1179–1181.
Published In
Expert Rev Anticancer Ther
DOI
EISSN
1744-8328
Publication Date
November 2021
Volume
21
Issue
11
Start / End Page
1179 / 1181
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasms
- Immunotherapy
- Immunologic Factors
- Humans
- Female
- Cancer Vaccines
- Breast Neoplasms
- Antigens, Neoplasm
- 3211 Oncology and carcinogenesis